The incidence of narcolepsy in Europe: before, during, and after the influenza A (H1N1) pdm09 pandemic and vaccination campaigns
L Wijnans, C Lecomte, C de Vries, D Weibel… - Vaccine, 2013 - Elsevier
BACKGROUND: In August 2010 reports of a possible association between exposure to
AS03 adjuvanted pandemic A (H1N1) pdm09 vaccine and occurrence of narcolepsy in …
AS03 adjuvanted pandemic A (H1N1) pdm09 vaccine and occurrence of narcolepsy in …
Combining electronic healthcare databases in Europe to allow for large‐scale drug safety monitoring: the EU‐ADR Project
Purpose In this proof‐of‐concept paper we describe the framework, process, and
preliminary results of combining data from European electronic healthcare record (EHR) …
preliminary results of combining data from European electronic healthcare record (EHR) …
Risk of acute myocardial infarction during use of individual NSAIDs: a nested case-control study from the SOS project
GMC Masclee, H Straatman, A Arfè, J Castellsague… - PLoS …, 2018 - journals.plos.org
Background Use of selective COX-2 non-steroidal anti-inflammatory drugs (NSAIDs)(coxibs)
has been associated with an increased risk of acute myocardial infarction (AMI). However …
has been associated with an increased risk of acute myocardial infarction (AMI). However …
Risk of ischemic stroke and the use of individual non-steroidal anti-inflammatory drugs: A multi-country European database study within the SOS Project
Background and purpose A multi-country European study using data from six healthcare
databases from four countries was performed to evaluate in a large study population (> 32 …
databases from four countries was performed to evaluate in a large study population (> 32 …
Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project
Objective Data from electronic healthcare records (EHR) can be used to monitor drug safety,
but in order to compare and pool data from different EHR databases, the extraction of …
but in order to compare and pool data from different EHR databases, the extraction of …
Electronic healthcare databases for active drug safety surveillance: is there enough leverage?
Purpose To provide estimates of the number and types of drugs that can be monitored for
safety surveillance using electronic healthcare databases. Methods Using data from eight …
safety surveillance using electronic healthcare databases. Methods Using data from eight …
Evaluation of electronic healthcare databases for post-marketing drug safety surveillance and pharmacoepidemiology in China
Y Yang, X Zhou, S Gao, H Lin, Y Xie, Y Feng, K Huang… - Drug safety, 2018 - Springer
Abstract Introduction Electronic healthcare databases (EHDs) are used increasingly for post-
marketing drug safety surveillance and pharmacoepidemiology in Europe and North …
marketing drug safety surveillance and pharmacoepidemiology in Europe and North …
[HTML][HTML] Data extraction and management in networks of observational health care databases for scientific research: a comparison of EU-ADR, OMOP, Mini-Sentinel …
Conclusion: Using our conceptual framework we found several areas that would benefit from
research to identify optimal standards for production of empirical knowledge from existing …
research to identify optimal standards for production of empirical knowledge from existing …
An effective method of large scale ontology matching
G Diallo - Journal of Biomedical Semantics, 2014 - Springer
Background We are currently facing a proliferation of heterogeneous biomedical data
sources accessible through various knowledge-based applications. These data are …
sources accessible through various knowledge-based applications. These data are …
The EU‐ADR Web Platform: delivering advanced pharmacovigilance tools
JL Oliveira, P Lopes, T Nunes… - … and drug safety, 2013 - Wiley Online Library
Purpose Pharmacovigilance methods have advanced greatly during the last decades,
making post‐market drug assessment an essential drug evaluation component. These …
making post‐market drug assessment an essential drug evaluation component. These …